EI Risk Assessment - European Medicines Agency

1 Author: Andrew Teasdale and Laura Rutter (on behalf of EFPIA) date : 5 april 2016 * Version: Final Elemental Impurity Risk Assessment - Case Studies 2 Overview Using the principles outlined in ICH Q3D and training modules we will: Present a series of risk assessments based on actual products. Examining different routes of administration. Through this seek to highlight there is more than one approach, illustrated through the examples shown. Marketing application example summary and proposed location. Approach to products during clinical development. 3 ICH Q3D Guideline for Elemental Impurities Practical Implementation of ICH Q3D ICH Q3D recommends taking a risk based approach.

www.efpia.eu 1 Author: Andrew Teasdale and Laura Rutter (on behalf of EFPIA) Date: 5 April 2016 * Version: Final . Elemental Impurity Risk Assessment -

Tags:

  Date, 2016, April, April 2016

Information